Incoming News

West Midlands Centre for Adverse Drug Reactions (UK): Panoramas: Endovascular treatments of atherosclerotic carotid diseases in China

AGES ADR feed - Fri, 09/03/2010 - 01:49
Stroke induces heavy socioeconomic burdens particularly in developing countries. Considering the multisectional discrepancies, strategies of stroke prevention and management adapted for western populations are not always applicable for patients in developing countries. Currently, carotid endarterectomy is the recommended treatment for severe carotid stenosis in the west. Carotid angioplasty and stenting is an alternative treatment only for patients with a high surgery risk. However, in developing countries such as China, where carotid endarterectomy is widely unavailable, Carotid angioplasty and stenting has developed rapidly in recent years and is becoming a choice of treatment for occlusive carotid diseases. (Source: International Journal of Stroke)
Categories: Adverse Reactions

West Midlands Centre for Adverse Drug Reactions (UK): Reviews: Cerebral amyloid angiopathy in East and West

AGES ADR feed - Fri, 09/03/2010 - 01:49
Cerebral amyloid angiopathy, a vasculopathy characterised by the deposition of amyloid fibrils in the arteries and arterioles in the cerebral cortex and meninges, has been reported to be associated with intracerebral haemorrhage and cognitive impairment in the elderly. Advances in neuroimaging and validation of the clinical diagnostic criteria aid in making a correct clinical diagnosis. Associations with Alzheimer's disease, asymptomatic microbleeds and white matter changes on neuroimaging have an influence on the clinical treatment for patients with probable cerebral amyloid angiopathy. Reviewing the reports from Asian countries, we found that patients with cerebral amyloid angiopathy have a strong age‐related prevalence and a consistent association with dementia, but a weaker correlati...
Categories: Adverse Reactions

West Midlands Centre for Adverse Drug Reactions (UK): Leading opinions: Is there a role for echocardiography in intracerebral haemorrhage?

AGES ADR feed - Fri, 09/03/2010 - 01:49
Hypertension (HTN) is the most common cause of non‐traumatic ICH, yet echocardiography, which can stage hypertensive heart disease (HHD), is not part of the routine evaluation of patients with ICH. Previous studies have shown that angiotensin converting enzyme inhibitors and angiotensin receptor blockers are associated with regression of left ventricular hypertrophy (LVH) and reversal of myocardial fibrosis. Improvement in these architectural changes in the heart has been shown to improve outcomes and prevent major adverse cardiac events, including stroke. Obtaining echocardiography on ICH patients routinely could help to access the prevalence of HHD and to tailor antihypertensive regimens in this high risk group of patients. Further study is required to determine whether angiotensin dir...
Categories: Adverse Reactions

West Midlands Centre for Adverse Drug Reactions (UK): Pancreatic cancer drug trialled

AGES ADR feed - Fri, 09/03/2010 - 00:59
A clinical trial of a new drug on patients with advanced (stage IV) pancreatic cancer has been launched (Source: Pharmacy Europe)
Categories: Adverse Reactions

West Midlands Centre for Adverse Drug Reactions (UK): Varicella zoster virus vax "well tolerated" in Europe

AGES ADR feed - Fri, 09/03/2010 - 00:55
(Source: Reactions)

MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.

Categories: Adverse Reactions

West Midlands Centre for Adverse Drug Reactions (UK): Paracetamol use linked to adolescent asthma

AGES ADR feed - Fri, 09/03/2010 - 00:55
(Source: Reactions)

MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.

Categories: Adverse Reactions

West Midlands Centre for Adverse Drug Reactions (UK): Safety information updated for Avastin in Canada

AGES ADR feed - Fri, 09/03/2010 - 00:55
(Source: Reactions)

MedWorm Message: Register for MedMatcha, MedWorm's medical advertising network, and receive $5 free advertising.

Categories: Adverse Reactions
Syndicate content